Skip to main content Back to Top
Advertisement

1/21/2020

Acyclovir Injection

Products Affected - Description

    • Acyclovir sodium injection, AuroMedics, 50 mg/mL, 10 mL vial, 10 count, NDC 55150-0154-10
    • Acyclovir sodium injection, Fresenius Kabi, 50 mg/mL, 10 mL vial, 10 count, NDC 63323-0325-10
    • Acyclovir sodium injection, Fresenius Kabi, 50 mg/mL, 20 mL vial, 10 count, NDC 63323-0325-20

Reason for the Shortage

    • AuroMedics did not provide a reason for the shortage.
    • Fresenius Kabi has acyclovir injection on shortage due to increased demand.

Available Products

    • Acyclovir sodium injection, AuroMedics, 50 mg/mL, 20 mL vial, 10 count, NDC 55150-0155-20

Estimated Resupply Dates

    • AuroMedics has acyclovir 50 mg/mL 10 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Fresenius Kabi has acyclovir 50 mg/mL 10 mL and 20 mL vials on back order and the company cannot estimate a release date. Check wholesalers for inventory.

Updated

Updated January 21, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 4, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins